Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick C Ma

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2019
(Not Giving Up) The Marathon Race of MET Targeting Therapy: Are We There Yet?Patrick C Ma
Cancer Discovery|August 6, 2015
MET receptor juxtamembrane exon 14 alternative spliced variant: novel cancer genomic predictive biomarkerPatrick C Ma
Cleveland Clinic Journal of Medicine|May 23, 2012
Personalized targeted therapy in advanced non-small cell lung cancerPatrick C Ma
Current Treatment Options in Oncology|November 19, 2013
Overview of various techniques/platforms with critical evaluation of eachEberechi Agwa, Patrick C Ma
Journal of the National Comprehensive Cancer Network : JNCCN|September 26, 2009
Novel targets for therapeutic agents in small cell lung cancerPatrick C Ma, Ravi Salgia
Cancer Discovery|May 16, 2012
Anti-MET targeted therapy has come of age: the first durable complete response with MetMAb in metastatic gastric cancerYan Feng, Patrick C Ma
Lung Cancer (Auckland, N.Z.)|February 18, 2017
MET targeted therapy for lung cancer: clinical development and future directionsYan Feng, Patrick C Ma
Cancer Management and Research|October 21, 2014
Targeting the MET receptor tyrosine kinase in non-small cell lung cancer: emerging role of tivantinibEberechi S Agwa, Patrick C Ma
Journal of Hematology & Oncology|December 10, 2019
Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapyZuan-Fu Lim, Patrick C Ma
Genes & Cancer|December 25, 2012
Cancer genes in lung cancer: racial disparities: are there any?Ahmed El-Telbany, Patrick C Ma
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2019
(Not Giving Up) The Marathon Race of MET Targeting Therapy: Are We There Yet?Patrick C Ma
Cancer Discovery|August 6, 2015
MET receptor juxtamembrane exon 14 alternative spliced variant: novel cancer genomic predictive biomarkerPatrick C Ma
Cleveland Clinic Journal of Medicine|May 23, 2012
Personalized targeted therapy in advanced non-small cell lung cancerPatrick C Ma
Current Treatment Options in Oncology|November 19, 2013
Overview of various techniques/platforms with critical evaluation of eachEberechi Agwa, Patrick C Ma
Journal of the National Comprehensive Cancer Network : JNCCN|September 26, 2009
Novel targets for therapeutic agents in small cell lung cancerPatrick C Ma, Ravi Salgia
Cancer Discovery|May 16, 2012
Anti-MET targeted therapy has come of age: the first durable complete response with MetMAb in metastatic gastric cancerYan Feng, Patrick C Ma
Lung Cancer (Auckland, N.Z.)|February 18, 2017
MET targeted therapy for lung cancer: clinical development and future directionsYan Feng, Patrick C Ma
Cancer Management and Research|October 21, 2014
Targeting the MET receptor tyrosine kinase in non-small cell lung cancer: emerging role of tivantinibEberechi S Agwa, Patrick C Ma
Journal of Hematology & Oncology|December 10, 2019
Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapyZuan-Fu Lim, Patrick C Ma
Genes & Cancer|December 25, 2012
Cancer genes in lung cancer: racial disparities: are there any?Ahmed El-Telbany, Patrick C Ma
Pageof 9